INVESTIGATING THE ROLE OF B-CELL ACTIVATING FACTOR (BAFF), GALECTIN-9, AND CD73 IN THE PATHOGENESIS OF VITILIGO: A CORRELATIVE STUDY WITH BIOCHEMICAL FACTORS
DOI:
https://doi.org/10.61796/jmgcb.v2i1.1073Keywords:
Vitiligo, Immune dysregulation, BAFF (B-cell Activating Factor), Galectin-9, CD73Abstract
Objective: To investigate the involvement of immune-regulatory molecules—B-cell Activating Factor (BAFF), Galectin-9, and CD73—in the pathogenesis of vitiligo. Methods: A case-control study involving 50 patients with active vitiligo and 50 healthy controls. Peripheral blood and skin biopsy samples were collected to measure the concentrations of BAFF, Galectin-9, and CD73. Statistical analysis was conducted to evaluate differences and correlations between these markers. Results: The results showed that the levels of B-cell Activating Factor (BAFF) were significantly higher in vitiligo patients (150.64 ng/mL) compared to healthy controls (85.16 ng/mL). Similarly, Galectin-9 concentrations were elevated in patients (203.02 ng/mL) relative to controls (149.68 ng/mL). In contrast, CD73 levels were lower in vitiligo patients (49.66 ng/mL) compared to healthy controls (79.37 ng/mL), although this difference was not statistically significant. Correlation analysis revealed a positive association between BAFF and Galectin-9, while CD73 exhibited a negative correlation with both BAFF and Galectin-9. Novelty: The study identifies BAFF and Galectin-9 as potential biomarkers for vitiligo severity and suggests CD73 as a modulator of immune responses. This adds new insights into the immunopathology of vitiligo and highlights potential therapeutic targets
References
T. Fukumoto et al., “ARID2 deficiency correlates with the response to immune checkpoint blockade in melanoma,” J. Invest. Dermatol., vol. 141, no. 6, pp. 1564–1572, 2021.
P. Carlucci, F. Spataro, M. Cristallo, M. Di Gioacchino, E. Nettis, and S. Gangemi, “Immune-Molecular Link between Thyroid and Skin Autoimmune Diseases: A Narrative Review,” J. Clin. Med., vol. 13, no. 18, 2024.
S. Arora and P. Ligoxygakis, “Beyond host defense: Deregulation of Drosophila immunity and age-dependent neurodegeneration,” Front. Immunol., vol. 11, p. 1574, 2020.
F. Ramírez-Valle, J. C. Maranville, S. Roy, and R. M. Plenge, “Sequential immunotherapy: towards cures for autoimmunity,” Nat. Rev. Drug Discov., pp. 1–24, 2024.
L. Kruk, A. Braun, E. Cosset, T. Gudermann, and E. Mammadova-Bach, “Galectin functions in cancer-associated inflammation and thrombosis,” Front. Cardiovasc. Med., vol. 10, p. 1052959, 2023.
Y. Liu, H. Chen, Z. Chen, J. Qiu, H. Pang, and Z. Zhou, “Novel roles of the Tim family in immune regulation and autoimmune diseases,” Front. Immunol., vol. 12, p. 748787, 2021.
A. L. Giuliani, A. C. Sarti, and F. Di Virgilio, “Ectonucleotidases in acute and chronic inflammation,” Front. Pharmacol., vol. 11, p. 619458, 2021.
S. Wang, S. Gao, D. Zhou, X. Qian, J. Luan, and X. Lv, “The role of the CD39–CD73–adenosine pathway in liver disease,” J. Cell. Physiol., vol. 236, no. 2, pp. 851–862, 2021.
S. A. Beheshti, K. Shamsasenjan, M. Ahmadi, and B. Abbasi, “CAR Treg: A new approach in the treatment of autoimmune diseases,” Int. Immunopharmacol., vol. 102, p. 108409, 2022.
B. Alkhalifah, A., Alsantali, A., & Wang, “12,” Immunol. Invest., vol. 50, no. 1, pp. 23–35, 2021, [Online]. Available: https://doi.org/10.1080/08820139.2020.1780877
W. Z. Atwa, M. A., Fathy, A., & Mostafa, “Serum galectin-9 levels and its relation to disease severity in vitiligo.pdf,” J. Cosmet. Dermatol., vol. 21, no. 2, pp. 685–691, 2022, [Online]. Available: https://doi.org/10.1111/jocd.14377
S. Ramos-Casals, M., Brito-Zerón, P., & Bombardieri, “BAFF a key cytokine in autoimmune diseases.pdf,” Front. Immunol., vol. 11, 2020, [Online]. Available: https://doi.org/10.3389/fimmu.2020.01574
N. Ezzedine, K., Eleftheriadou, V., Whitton, M., & van Geel, “Vitiligo.pdf,” Lancet, vol. 398, no. 10301, pp. 1526–1536, 2021.
Y. Zhou, L., He, W., Zhong, Y., & Fan, “CD73 and autoimmune diseases: Emerging roles in immunity and inflammation,” Immunol. Rev., vol. 297, no. 1, pp. 209–231, 2020.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2024 Hussein Ali Mohammed AL-Ukaily
This work is licensed under a Creative Commons Attribution 4.0 International License.
